Patent – Infringement. The Supreme Court allowed the appeal of the proprietor of a patent (Lilly) and held that a group of companies (together, Actavis) seeking to market a similar product for the treatment of cancer had infringed Lilly's patent in the United Kingdom, France, Spain and Italy. Actavis' cross-appeal was dismissed on the basis that, if its products did not directly infringe, they would indirectly infringe.